Glofitamab ELISA Kit (GXEL00118)

(No reviews yet) Write a Review

SKU:
GXEL00118
Product Type:
ELISA Kit
Assay Type:
Quantitative
Detection Method:
Colorimetric
Sensitivity:
0.156 μg/ml
Range:
0.31-5 μg/mL
Size:
96T
Synonyms:
CD20-TCB (2:1), RG-6026, 2229047-91-8
€0.00
Frequently bought together:

Description

Glofitamab ELISA Kit

Assay Genie's Glofitamab ELISA Kit (SKU: GXEL00118) provides researchers with a reliable quantitative ELISA for the quantitative measurement of Glofitamab in Plasma, Serum. Offering a measurement range of 0.31-5 μg/mL and a sensitivity of 0.156 μg/ml, the kit is optimised for precision and ease of use in the research laboratory.

Glofitamab (RG6026) is a novel T-cell-engaging, bispecific antibody that binds bivalently to CD20 on B cells, and monovalently to CD3 on T cells. In study NP30179 (NCT03075696), an ongoing Phase I/II dose-escalation and expansion study, glofitamab fixed-dosing (0.6-25mg) with obinutuzumab pre-treatment (Gpt) achieved high, durable CRs with manageable safety in pts with heavily pre-treated R/R NHL (Dickinson et al. EHA 2020). Step-up dosing (SUD) of glofitamab, in addition to Gpt, allowed dose-escalation up to the highest planned dose of 30mg to maximize efficacy, while mitigating cytokine release syndrome (CRS; [Hutchings et al. J Clin Oncol 2021]). We present updated duration of response (DoR) data from the glofitamab monotherapy fixed-dosing and SUD cohorts of study NP30179 in pts with R/R NHL.

Complete with standards, buffers and detection reagents, the Glofitamab ELISA Kit streamlines assay set-up so you can focus on results. Choose the Glofitamab ELISA Kit from Assay Genie for quality you can trust.

View AllClose